Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention

G. Caocci, O. Mulas, M. Bonifacio, E. Abruzzese, S. Galimberti, E.M. Orlandi, A. Iurlo, M. Annunziata, L. Luciano, F. Castagnetti, A. Gozzini, F. Stagno, G. Binotto, P. Pregno, F. Albano, B. Martino, C. Fozza, L. Scaffidi, M.M. Trawinska, C. BaratèC. Elena, D. Cattaneo, E. Scalzulli, G. La Nasa, R. Foà, M. Breccia

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)124-127
Number of pages4
JournalInternational Journal of Cardiology
Volume288
DOIs
Publication statusPublished - 2019

Keywords

  • Chronic myeloid leukemia
  • Recurrent arterial occlusive event
  • Secondary prophylaxis
  • antithrombocytic agent
  • bosutinib
  • dasatinib
  • hydroxymethylglutaryl coenzyme A reductase inhibitor
  • nilotinib
  • ponatinib
  • adult
  • aged
  • anticoagulant therapy
  • Article
  • cancer chemotherapy
  • cardiovascular risk
  • chronic myeloid leukemia
  • cohort analysis
  • human
  • incidence
  • major clinical study
  • peripheral occlusive artery disease
  • priority journal
  • recurrent disease
  • secondary prevention

Cite this

Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention. / Caocci, G.; Mulas, O.; Bonifacio, M.; Abruzzese, E.; Galimberti, S.; Orlandi, E.M.; Iurlo, A.; Annunziata, M.; Luciano, L.; Castagnetti, F.; Gozzini, A.; Stagno, F.; Binotto, G.; Pregno, P.; Albano, F.; Martino, B.; Fozza, C.; Scaffidi, L.; Trawinska, M.M.; Baratè, C.; Elena, C.; Cattaneo, D.; Scalzulli, E.; La Nasa, G.; Foà, R.; Breccia, M.

In: International Journal of Cardiology, Vol. 288, 2019, p. 124-127.

Research output: Contribution to journalArticle

Caocci, G, Mulas, O, Bonifacio, M, Abruzzese, E, Galimberti, S, Orlandi, EM, Iurlo, A, Annunziata, M, Luciano, L, Castagnetti, F, Gozzini, A, Stagno, F, Binotto, G, Pregno, P, Albano, F, Martino, B, Fozza, C, Scaffidi, L, Trawinska, MM, Baratè, C, Elena, C, Cattaneo, D, Scalzulli, E, La Nasa, G, Foà, R & Breccia, M 2019, 'Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention', International Journal of Cardiology, vol. 288, pp. 124-127. https://doi.org/10.1016/j.ijcard.2019.04.051
Caocci, G. ; Mulas, O. ; Bonifacio, M. ; Abruzzese, E. ; Galimberti, S. ; Orlandi, E.M. ; Iurlo, A. ; Annunziata, M. ; Luciano, L. ; Castagnetti, F. ; Gozzini, A. ; Stagno, F. ; Binotto, G. ; Pregno, P. ; Albano, F. ; Martino, B. ; Fozza, C. ; Scaffidi, L. ; Trawinska, M.M. ; Baratè, C. ; Elena, C. ; Cattaneo, D. ; Scalzulli, E. ; La Nasa, G. ; Foà, R. ; Breccia, M. / Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention. In: International Journal of Cardiology. 2019 ; Vol. 288. pp. 124-127.
@article{1a7de1bdea5a4e679b9c114974a67f11,
title = "Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention",
keywords = "Chronic myeloid leukemia, Recurrent arterial occlusive event, Secondary prophylaxis, antithrombocytic agent, bosutinib, dasatinib, hydroxymethylglutaryl coenzyme A reductase inhibitor, nilotinib, ponatinib, adult, aged, anticoagulant therapy, Article, cancer chemotherapy, cardiovascular risk, chronic myeloid leukemia, cohort analysis, human, incidence, major clinical study, peripheral occlusive artery disease, priority journal, recurrent disease, secondary prevention",
author = "G. Caocci and O. Mulas and M. Bonifacio and E. Abruzzese and S. Galimberti and E.M. Orlandi and A. Iurlo and M. Annunziata and L. Luciano and F. Castagnetti and A. Gozzini and F. Stagno and G. Binotto and P. Pregno and F. Albano and B. Martino and C. Fozza and L. Scaffidi and M.M. Trawinska and C. Barat{\`e} and C. Elena and D. Cattaneo and E. Scalzulli and {La Nasa}, G. and R. Fo{\`a} and M. Breccia",
note = "Export Date: 24 September 2019 CODEN: IJCDD Correspondence Address: Caocci, G.; SC Ematologia e CTMO, Ospedale Businco, Dipartimento di Scienze Mediche e Sanit{\`a} Pubblica, Universit{\`a} di Cagliari, Via Jenner, sn, Italy; email: giovanni.caocci@unica.it",
year = "2019",
doi = "10.1016/j.ijcard.2019.04.051",
language = "English",
volume = "288",
pages = "124--127",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention

AU - Caocci, G.

AU - Mulas, O.

AU - Bonifacio, M.

AU - Abruzzese, E.

AU - Galimberti, S.

AU - Orlandi, E.M.

AU - Iurlo, A.

AU - Annunziata, M.

AU - Luciano, L.

AU - Castagnetti, F.

AU - Gozzini, A.

AU - Stagno, F.

AU - Binotto, G.

AU - Pregno, P.

AU - Albano, F.

AU - Martino, B.

AU - Fozza, C.

AU - Scaffidi, L.

AU - Trawinska, M.M.

AU - Baratè, C.

AU - Elena, C.

AU - Cattaneo, D.

AU - Scalzulli, E.

AU - La Nasa, G.

AU - Foà, R.

AU - Breccia, M.

N1 - Export Date: 24 September 2019 CODEN: IJCDD Correspondence Address: Caocci, G.; SC Ematologia e CTMO, Ospedale Businco, Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Via Jenner, sn, Italy; email: giovanni.caocci@unica.it

PY - 2019

Y1 - 2019

KW - Chronic myeloid leukemia

KW - Recurrent arterial occlusive event

KW - Secondary prophylaxis

KW - antithrombocytic agent

KW - bosutinib

KW - dasatinib

KW - hydroxymethylglutaryl coenzyme A reductase inhibitor

KW - nilotinib

KW - ponatinib

KW - adult

KW - aged

KW - anticoagulant therapy

KW - Article

KW - cancer chemotherapy

KW - cardiovascular risk

KW - chronic myeloid leukemia

KW - cohort analysis

KW - human

KW - incidence

KW - major clinical study

KW - peripheral occlusive artery disease

KW - priority journal

KW - recurrent disease

KW - secondary prevention

U2 - 10.1016/j.ijcard.2019.04.051

DO - 10.1016/j.ijcard.2019.04.051

M3 - Article

VL - 288

SP - 124

EP - 127

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -